CYPHERPUNK TECHNOLOGIES INC. Foreign Currency Transaction Loss, before Tax
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Foreign Currency Transaction Loss, before Tax of $48.00 thousand for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ForeignCurrencyTransactionLossBeforeTax · last filed 2020-08-13
- CYPHERPUNK TECHNOLOGIES INC. foreign currency transaction loss, before tax for the quarter ending 2020-06-30 was -$943.00K.
- CYPHERPUNK TECHNOLOGIES INC. foreign currency transaction loss, before tax for the quarter ending 2020-03-31 was $991.00K.
| Period end | Foreign Currency Transaction Loss, before Tax 3 month | Foreign Currency Transaction Loss, before Tax 6 month |
|---|---|---|
| 2020-06-30 | -$943.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $48.00K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $991.00K 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |